肥厚性和瘢痕疙瘩治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00007237
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Buy Now

[研究报告]2019年肥厚性疤痕疙瘩治疗市场价值为44.9899亿美元,预计到2027年将达到99.7269亿美元;预计 2020 年至 2027 年复合年增长率为 10.6%。

肥厚性疤痕是指由于生长原因而出现的增厚、宽阔、经常隆起的疤痕。受伤。肥厚性疤痕通常是对创伤或损伤的异常反应的结果。疤痕疙瘩是一种淡红色结节,外观凸起并在受伤部位形成。疤痕疙瘩可能发生在身体的任何部位;然而,上胸部、肩膀和上背部最容易形成疤痕疙瘩。

肥厚性疤痕疙瘩治疗市场范围包括疤痕类型、产品类型、最终用户和地区。肥厚性疤痕和疤痕疙瘩治疗市场按地区划分为北美、欧洲、亚太地区、中东和北美。非洲、南美洲和中美洲。该报告提供了对肥厚性和疤痕疙瘩治疗市场的见解和深入分析,重点关注各种参数,例如市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争格局分析。它还包括所有地区的 COVID-19 影响分析。由于各国的封锁限制了不同非必需医疗产品的供应链,预计未来几年市场增长速度可能会放缓。疫情对美容行业产生了广泛影响,间接禁止了疤痕治疗。

肥厚性疤痕和瘢痕疙瘩治疗市场的利润丰厚区域

市场洞察

激光治疗的优势

技术的进步导致激光特别是585 nm PDL、Q的成功使用- 切换 532 nm 倍频 Nd: YAG 和 CO2 激光以及其他类型的激光,用于治疗肥厚性疤痕和疤痕疙瘩。激光治疗有助于防止术后疤痕形成;它可以减轻疼痛和瘙痒,并允许因疤痕而受到限制的活动。该疗法广泛用于治疗烧伤引起的肥厚性疤痕和疤痕疙瘩。根据“肥厚性烧伤疤痕的激光治疗:综合回顾”,发表于 2020 年 1 月,超过 70% 的肥厚性疤痕都与烧伤相关。同样,根据世界卫生组织(WHO)的说法,烧伤是主要的公共卫生问题。每年约有 265,000 人因烫伤、电烧伤和其他烧伤形式死亡。此外,90%的烧伤发生率发生在低收入和中等收入国家。

由于胶原蛋白过度沉积导致增生性疤痕的产生,从而导致疤痕隆起,激光治疗被证明对他们有效。此外,由于是一种微创方法,它可以确保减少疤痕厚度、疼痛和术后恢复时间。它还有助于避免手术切除的需要,并改善皮肤色素沉着、柔韧度、高度、瘙痒、纹理和热敏感性以及受影响区域的其他皮肤状况。这种治疗程序也被证明具有成本效益,特别是对于那些选择医疗旅游的人来说。由于这些优点,对激光治疗肥厚性疤痕和疤痕疙瘩的需求很高。

基于疤痕类型的洞察

基于疤痕类型,肥厚性和疤痕疙瘩治疗市场分为肥厚性和疤痕疙瘩。由于肥厚性疤痕更为常见,因此肥厚性疤痕在 2019 年占据了更大的市场份额。此外,这些疤痕不会生长到原始伤口的边界之外,并且最终会变小。此外,肥厚性疤痕的治疗通常需要在轻伤和激光治疗过程中使用凝胶、乳膏和硅胶片等非侵入性手术。因此,预计该细分市场在预测期内的市场复合年增长率将更高。

全球肥厚性疤痕和瘢痕疙瘩治疗市场(按疤痕类型划分) 2019年& 2027

基于产品类型的洞察

根据产品类型,对肥厚性疤痕和疤痕疙瘩治疗市场进行细分分为激光产品、局部产品、注射剂和其他产品。注射剂细分市场在 2019 年占据最大市场份额,预计在预测期内复合年增长率最高。

基于最终用户的见解< /p>

根据最终用户,肥厚性疤痕和疤痕疙瘩治疗市场分为医院、诊所和家庭护理。医院细分市场在 2019 年占据最大市场份额,预计在预测期内复合年增长率最高。

战略洞察

公司通常采用合作伙伴关系和并购等无机战略来满足不断变化的客户需求并在全球范围内维护其品牌声誉。肥厚性疤痕和疤痕疙瘩治疗市场的市场参与者也采取产品推出和扩张等有机策略,以扩大其在全球的足迹和产品组合,并满足不断增长的需求。

 

按疤痕类型

  • 肥厚性
  • 疤痕疙瘩

按产品类型

  • 激光产品
    • CO2
    • 脉冲染色
    • 其他激光产品
  • 局部产品
      < li>面霜
    • 凝胶
    • 硅胶片
    • 其他外用产品
  • 注射剂
  • 其他产品

最终用户

  • 医院
  • 诊所
  • 家庭护理

按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
    • 欧洲
      • 法国
      • 德国
      • 意大利
      • 英国
      • 西班牙< /li>
      • 欧洲其他地区
    • 亚太地区 (APAC)
      • 中国
      • 印度
      • 韩国
      • 日本
      • 澳大利亚
      • 亚太地区其他地区
    • 中东和非洲非洲 (MEA)
      • 南非
      • 沙特阿拉伯
      • 阿联酋
      • 中东和非洲其他地区
    • 南美洲和中美洲 (SCAM)
      • 巴西
      • 阿根廷
      • 其他 SCAM
  • ul>

    公司简介

    • Alliance Pharma plc
    • Mölnlycke HEALTH CARE AB。
    • 史密斯& Nephew
    • Newmedical Technology Inc.
    • Rejüvaskin
    • Sonoma Pharmaceuticals, Inc.
    • Suneva Medical
    • HRA Pharma
    • Lumenis
    • Perrigo Company plc。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Hypertrophic and Keloid Scars ?

A hypertrophic scar refers to a thickened, wide, often raised scar that occurs due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any part of the body; however, the upper chest, shoulders, and upper back are most prone to keloid formation.

What are the driving factors for the hypertrophic and keloid scar treatment market across the globe?

The growth of the market is attributed to advantages of laser treatment and increasing incidences of injuries. However, unavailability of universal treatment due to high costs, side effects, and scanty awareness hinder the market growth.

What is the cost of hypertrophic and keloid scar treatment?

The costs of the treatments of these scars are much higher, and they may cost US$ 1,000–5,000, or more, per treatment. The cost may also differ from product to product and treatment cycles.

The List of Companies - Hypertrophic and Keloid Scar Treatment Market

  1. Alliance Pharma plc
  2. Mölnlycke HEALTH CARE AB.
  3. Smith & Nephew
  4. Newmedical Technology Inc.
  5. Rejûvaskin
  6. Sonoma Pharmaceuticals, Inc.
  7. Suneva Medical
  8. HRA Pharma
  9. Lumenis
  10. Perrigo Company plc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports